CD4 and cervical squamous intraepithelial neoplasia: Of note, in this study we have shown that priming with pNGVL4a-CRT-E6E7L2 DNA vaccine followed by boosting with TA-CIN protein vaccine is capable of generating a TA-CIN-specific CD4+ T cell response.